{"id":406463,"date":"2025-09-09T00:30:00","date_gmt":"2025-09-08T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/utiliser-les-antiresorptifs-et-les-osteoanabolisants-de-maniere-ciblee-et-eviter-les-effets-de-rebond\/"},"modified":"2025-09-09T01:58:07","modified_gmt":"2025-09-08T23:58:07","slug":"utiliser-les-antiresorptifs-et-les-osteoanabolisants-de-maniere-ciblee-et-eviter-les-effets-de-rebond","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/utiliser-les-antiresorptifs-et-les-osteoanabolisants-de-maniere-ciblee-et-eviter-les-effets-de-rebond\/","title":{"rendered":"Utiliser les antir\u00e9sorptifs et les ost\u00e9oanabolisants de mani\u00e8re cibl\u00e9e et \u00e9viter les effets de &#8220;rebond"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;ost\u00e9oporose post-m\u00e9nopausique chez la femme est une cons\u00e9quence de la baisse du taux d&#8217;\u0153strog\u00e8nes et s&#8217;accompagne d&#8217;une perte osseuse rapide (&#8220;ost\u00e9oporose \u00e0 forte rotation&#8221;). Pour obtenir des effets durables, des concepts th\u00e9rapeutiques \u00e0 long terme sont n\u00e9cessaires &#8211; si les m\u00e9dicaments contre l&#8217;ost\u00e9oporose sont arr\u00eat\u00e9s sans traitement de suivi, l&#8217;effet ost\u00e9oprotecteur est perdu et une nouvelle perte de densit\u00e9 osseuse risque de se produire. Les strat\u00e9gies de traitement s\u00e9quentiel sont donc essentielles pour pr\u00e9venir les effets de &#8220;rebond&#8221;.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Futiliser-les-antiresorptifs-et-les-osteoanabolisants-de-maniere-ciblee-et-eviter-les-effets-de-rebond%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;ost\u00e9oporose post-m\u00e9nopausique chez la femme est une cons\u00e9quence de la baisse du taux d&#8217;\u0153strog\u00e8nes et s&#8217;accompagne d&#8217;une perte osseuse rapide (&#8220;ost\u00e9oporose \u00e0 forte rotation&#8221;). Pour obtenir des effets durables, des&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Futiliser-les-antiresorptifs-et-les-osteoanabolisants-de-maniere-ciblee-et-eviter-les-effets-de-rebond%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":406465,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Ost\u00e9oporose post-m\u00e9nopausique : approches th\u00e9rapeutiques \u00e0 long terme  ","footnotes":""},"category":[11549,11422,11315,11454,11464,11535],"tags":[69431,71474,41186,84417,84419,77830,71481,84418,58335,69448,71485,81339,41202],"powerkit_post_featured":[],"class_list":["post-406463","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-gynecologie","category-medecine-interne-generale","category-orthopedie","category-pharmacologie-et-toxicologie","category-rapports-de-congres","tag-alendronate-fr","tag-antiresorptifs","tag-denosumab-fr","tag-des-approches-therapeutiques-a-long-terme","tag-effets-de-rebond","tag-ibandronate","tag-osteoanabolisants","tag-osteoporose-post-menopausique","tag-raloxifene-fr","tag-risedronate-fr","tag-romosozumab-fr","tag-teriparatide-fr","tag-zoledronate-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-13 12:06:20","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":406446,"slug":"utilizzare-in-modo-mirato-gli-antiriassorbenti-e-gli-agenti-osteoanabolici-ed-evitare-gli-effetti-di-rimbalzo","post_title":"Utilizzare in modo mirato gli antiriassorbenti e gli agenti osteoanabolici ed evitare gli effetti di \"rimbalzo\".","href":"https:\/\/medizinonline.com\/it\/utilizzare-in-modo-mirato-gli-antiriassorbenti-e-gli-agenti-osteoanabolici-ed-evitare-gli-effetti-di-rimbalzo\/"},"pt_PT":{"locale":"pt_PT","id":406445,"slug":"utilizacao-orientada-de-anti-reabsortivos-e-agentes-osteoanabolicos-e-evitar-efeitos-de-ricochete","post_title":"Utiliza\u00e7\u00e3o orientada de anti-reabsortivos e agentes osteoanab\u00f3licos e evitar efeitos de \"ricochete","href":"https:\/\/medizinonline.com\/pt-pt\/utilizacao-orientada-de-anti-reabsortivos-e-agentes-osteoanabolicos-e-evitar-efeitos-de-ricochete\/"},"es_ES":{"locale":"es_ES","id":406459,"slug":"uso-selectivo-de-antirresortivos-y-agentes-osteoanabolicos-y-evitar-los-efectos-rebote","post_title":"Uso selectivo de antirresortivos y agentes osteoanab\u00f3licos y evitar los efectos \"rebote","href":"https:\/\/medizinonline.com\/es\/uso-selectivo-de-antirresortivos-y-agentes-osteoanabolicos-y-evitar-los-efectos-rebote\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/406463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=406463"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/406463\/revisions"}],"predecessor-version":[{"id":408095,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/406463\/revisions\/408095"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/406465"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=406463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=406463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=406463"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=406463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}